These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 29920909)
1. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer. van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer. Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968 [TBL] [Abstract][Full Text] [Related]
3. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Williams M; Perera M; Nouhaud FX; Coughlin G Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928 [TBL] [Abstract][Full Text] [Related]
4. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer. Brown WE; Koh CE; Badgery-Parker T; Solomon MJ Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910 [TBL] [Abstract][Full Text] [Related]
5. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion]. Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429 [TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701 [TBL] [Abstract][Full Text] [Related]
7. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255 [TBL] [Abstract][Full Text] [Related]
8. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database. Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E; World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391 [TBL] [Abstract][Full Text] [Related]
9. A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer. Simillis C; Baird DL; Kontovounisios C; Pawa N; Brown G; Rasheed S; Tekkis PP Ann Surg; 2017 Feb; 265(2):291-299. PubMed ID: 27537531 [TBL] [Abstract][Full Text] [Related]
10. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration? Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551 [TBL] [Abstract][Full Text] [Related]
11. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer? Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696 [TBL] [Abstract][Full Text] [Related]
12. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370 [TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer. Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132 [TBL] [Abstract][Full Text] [Related]
14. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer. Xin KY; Ng DW; Tan GH; Teo MC J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189 [TBL] [Abstract][Full Text] [Related]
15. The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer. Khan MAS; Ang CW; Hakeem AR; Scott N; Saunders RN; Botterill I J Gastrointest Surg; 2017 Dec; 21(12):2056-2065. PubMed ID: 28924962 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer. Rottoli M; Vallicelli C; Boschi L; Poggioli G Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560 [TBL] [Abstract][Full Text] [Related]
17. The role of pelvic exenteration in the management of recurrent rectal cancer. Kakuda JT; Lamont JP; Chu DZ; Paz IB Am J Surg; 2003 Dec; 186(6):660-4. PubMed ID: 14672775 [TBL] [Abstract][Full Text] [Related]
18. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases]. Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298 [TBL] [Abstract][Full Text] [Related]
19. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010. Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284 [TBL] [Abstract][Full Text] [Related]